After the second-trimester anomaly scan, healthy pregnant women will be offered inclusion in the study. Before inclusion, participants will fill out a questionnaire on the suitability of moderate physical exercise. After signing the consent form for the study, they will receive a random wrist-tracking device. The investigators will inform them about the use and possibilities of the wrist-tracking device. Suppose they will be randomly assigned to the group with a guided exercise program for pregnant women. In that case, they will also have a guided exercise program via a mobile application, where they will receive one of the exercises intended for pregnant women every day for up to 30 minutes. The investigators will also present and explain all the exercises to them, emphasizing the crucial role they play in our study. The investigators will also explain when they should stop exercising and immediately consult a perinatologist on the phone number provided. If they are randomly assigned to the control group, they will not receive exercise, but they can be physically active at their discretion.
The research will be a randomized intervention study on the impact of physical activity on physiological parameters and sleep duration during pregnancy. The research will be designed as a naturalistic study based on the guidelines for assessing the appropriateness of heart rate measurements with wrist-based heart rate monitors in biobehavioral research. The study will be conducted at the Gynecology Clinic at the University College of Medicine in Ljubljana.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Enrollment
40
Exercises for pregnant women in the SG will fall into moderate physical activity. They will be previously assessed by a perinatologist with a license to guide exercise during pregnancy. Each exercise will last 30 minutes, including initial warm-up exercises and final stretching exercises. The recommended moderate activity for pregnant women is at least 150 minutes per week, achieved on at least three days. For pregnant women aged 29 years or less, this means within the limits of a heart rate of 125 to 146 beats/min. For pregnant women aged 30 years or more, it is within the limits of a heart rate of between 121 and 141 beats per minute. According to the Borg scale of perceived exertion from six to 20, moderate exercise is rated between 13 and 14, corresponding to the specified heart rate thresholds. The pregnant woman will rate her exercise on the Borg perceived exertion scale from six to 20. The recommended number of steps per day will be at least 6,000.
In this group, pregnant women will be physically active at their discretion.
UMCLjubljana
Ljubljana, Slovenia
Resting heart rate variability
Heart rate variability (HRV) refers to the change in the interval between two beats (beat-to-beat interval) and allows a non-invasive assessment of the balance between the cardiac sympathetic and parasympathetic nervous systems. It will be measured during rest (sleep).
Time frame: From enrolment to the end of treatment at 5 weeks.
Resting cardiac coherence
Cardiac coherence, or physiological coherence, describes a measure of the stability and harmony of individual oscillatory regulatory systems in the body at any given time. It is reflected in the regular, sine-wave pattern of the heartbeat. It will be measured during rest (sleep).
Time frame: From enrolment to the end of treatment at 5 weeks.
Resting heart rate
Heart rate measured during sleep.
Time frame: From enrolment to the end of treatment at 5 weeks.
Sleep duration
Overall duration of sleep and deep sleep duration.
Time frame: From enrolment to the end of treatment at 5 weeks.
Systemic vascular resistance (SVR)
Systemic vascular resistance is the quantitative value for left ventricular afterload. In most patients, changes in vascular resistance reflect changes in arteriolar tone or changes in the viscosity of blood. It will be measured by USCOM.
Time frame: At the enrolment and conclusion of the study after 5 weeks.
BMI z-score
Measure of Insulin sensitivity
Time frame: At the enrolment and conclusion of the study after 5 weeks.
AST/ALT ratio
Measure of Insulin sensitivity
Time frame: At the enrolment and conclusion of the study after 5 weeks.
Fasting triglycerides
Measure of Insulin sensitivity
Time frame: At the enrolment and conclusion of the study after 5 weeks.
Fasting glucose
Measure of Insulin sensitivity
Time frame: At the enrolment and conclusion of the study after 5 weeks.
Fasting HDL
Measure of Insulin sensitivity
Time frame: At the enrolment and conclusion of the study after 5 weeks.
Homeostatic Model Assessment for Insulin Resistance (HOMA-IR)
Measure of Insulin sensitivity
Time frame: At the enrolment and conclusion of the study after 5 weeks.
Single-Point Insulin Sensitivity Estimator (SPISE)
Measure of Insulin sensitivity
Time frame: At the enrolment and conclusion of the study after 5 weeks.
Quantitative Insulin Sensitivity Check Index (QUICKI)
Measure of Insulin sensitivity
Time frame: At the enrolment and conclusion of the study after 5 weeks.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.